Abstract
Gap junction channels link cytoplasms of adjacent cells. Connexins, their constitutive proteins, are essential in cell homeostasis and are implicated in numerous physiological processes. Spermatogenesis is a sophisticated model of germ cell proliferation, differentiation, survival, and apoptosis, in which a connexin isotype, connexin 43, plays a crucial role as evidenced by genomic approaches based on gene deletion. The balance between cell proliferation/differentiation/apoptosis is a prerequisite for maintaining levels of spermatozoa essential for fertility and for limiting anarchic cell proliferation, a major risk of testis tumor. The present review highlights the emerging role of connexins in testis pathogenesis, focusing specifically on two intimately interconnected human testicular diseases (azoospermia with impaired spermatogenesis and testicular germ cell tumors), whose incidence increased during the last decades. This work proposes connexin 43 as a potential cancer diagnostic and prognostic marker, as well as a promising therapeutic target for testicular diseases.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha-fetoprotein
- AMH:
-
Anti-Müllerian hormone
- BTB:
-
Blood–testis barrier
- cAMP:
-
Cyclic adenosine monophosphate
- cGMP:
-
Cyclic guanosine monophosphate
- CIS:
-
Carcinoma in situ
- Cx:
-
Connexin
- G-CSF:
-
Granulocyte colony-stimulating factor
- GJA1:
-
Gap junction protein alpha 1
- GJIC:
-
Gap junction intercellular communication
- hCG:
-
Human chorionic gonadotropin
- KO:
-
Knock-out
- LDH:
-
Lactate dehydrogenase
- miRNA:
-
MicroRNA
- ODDD:
-
Oculodentodigital
- PGC:
-
Primordial germ cell
- PLAP:
-
Placental alkaline phosphatase
- SCO:
-
Sertoli-cell-only
References
Sharpe RM (2006) Pathways of endocrine disruption during male sexual differentiation and masculinisation. Best Pract Res Clin Endocrinol Metab 20:91–110
Skakkebæk NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978
Hardell L, Bavel B, Lindström G, Eriksson M, Carlberg M (2006) In utero exposure to persistent organic pollutants in relation to testicular cancer risk. Int J Androl 29:228–234
Pointis G, Segretain D (2005) Role of connexin-based gap junction channels in testis. Trends Endocrinol Metab 16:300–306
Gilleron J, Malassiné A, Carette D, Segretain D, Pointis G (2011) Chemical connexin impairment in the developing gonad associated with offspring infertility. Curr Med Chem 18:5145–5158
Pointis G, Gilleron J, Carette D, Segretain D (2011) Testicular connexin 43, a precocious molecular target for the effect of environmental toxicants on male fertility. Spermatogenesis 14:1–15
Leithe E, Sirnes S, Omori Y, Rivedal E (2006) Downregulation of gap junctions in cancer cells. Crit Rev Oncog 12:225–256
Nieschlag E, Behre HM (2000) Andrology, male reproductive health and dysfunction. Springer, Berlin, pp 83–87
Rajender S, Avery K, Agarwal A (2011) Epigenetics, spermatogenesis and male infertility. Mutat Res 727:62–71
Singh K, Jaiswal D (2011) Human male infertility: a complex multifactorial phenotype. Reprod Sci 18:418–425
Juneja SC, Barr KJ, Enders GC, Kidder GM (1999) Defects in the germ line and gonads of mice lacking connexin43. Biol Reprod 60:1263–1270
Plum A, Hallas G, Magin T, Dombrowski F, Hagendorff A, Schumacher B, Wolpert C, Kim J, Lamers WH, Evert M, Meda P, Traub O, Willecke K (2000) Unique and shared functions of different connexins in mice. Curr Biol 10:1083–1091
Roscoe WA, Barr KJ, Mhawi AA, Pomerantz DK, Kidder GM (2001) Failure of spermatogenesis in mice lacking connexin43. Biol Reprod 65:829–838
Brehm R, Zeiler M, Rüttinger C, Herde K, Kibschull M, Winterhager E, Willecke K, Guillou F, Lécureuil C, Steger K, Konrad L, Biermann K, Failing K, Bergmann MA (2007) Sertoli cell-specific knockout of connexin43 prevents initiation of spermatogenesis. Am J Pathol 171:19–31
Sridarhan S, Simon L, Meling DD, Cyr DG, Gutstein DE, Fishman GI, Guillou F, Cooke PS (2007) Proliferation of adult Sertoli cells following conditional knockout of the Gap junctional protein GJA1 (connexin43) in mice. Biol Reprod 76:804–812
Winterhager E, Pielensticker N, Freyer J, Ghanem A, Schrickel JW, Kim JS, Behr R, Grümmer R, Maass K, Urschel S, Lewalter T, Tiemann K, Simoni M, Willecke K (2007) Replacement of connexin43 by connexin26 in transgenic mice leads to dysfunctional reproductive organs and slowed ventricular conduction in the heart. BMC Dev Biol 7:26
Bruzzone R, White TW, Goodenough DA (1996) The cellular Internet: on-line with connexins. Bioessays 18:709–718
Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Güldenagel M, Deutsch U, Söhl G (2002) Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383:725–737
Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC (2003) Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 83:1359–1400
Chipman JK, Mally A, Edwards GO (2003) Disruption of gap junctions in toxicity and carcinogenicity. Toxicol Sci 71:146–153
Zoidl G, Dermietzel R (2010) Gap junctions in inherited human disease. Pflugers Arch 460:451–466
Pfenniger A, Wohlwend A, Kwak BR (2011) Mutations in connexin genes and disease. Eur J Clin Invest 41:103–116
Cronier L, Crespin S, Strale PO, Defamie N, Mesnil M (2009) Gap junctions and cancer: new functions for an old story. Antioxid Redox Signal 11:323–338
Trosko JE, Ruch RJ (2002) Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 3:465–482
Pointis G, Fiorini C, Gilleron J, Carette D, Segretain D (2007) Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis. Curr Med Chem 14:2288–2303
Yamasaki H, Omori Y, Krutovskikh V, Zhu W, Mironov N, Yamakage K, Mesnil M (1999) Connexins in tumour suppression and cancer therapy. Novartis Found Symp 219:241–254
Risley MS (2000) Connexin gene expression in seminiferous tubules of the Sprague–Dawley rat. Biol Reprod 62:748–754
Pointis G, Fiorini C, Gilleron J, Carette D, Segretain D (2008) Connexins in the male reproductive system. In: Harris A, Locke D (eds) Connexins, a guide. Humana Press, Totowa, pp 495–510
Pointis G, Gilleron J, Carette D, Segretain D (2010) Physiological and physiopathological aspects of connexins and communicating gap junctions in spermatogenesis. Phil Trans R Soc B 365:1607–1620
Okada K, Katagiri T, Tsunoda T, Mizutani Y, Suzuki Y, Kamada M, Fujioka T, Shuin T, Miki T, Nakamura Y (2003) Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray. Int J Oncol 23:1615–1635
Brehm R, Marks A, Rey R, Kliesch S, Bergmann M, Steger K (2002) Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma. J Pathol 197:647–653
White TW, Srinivas M, Ripps H, Trovato-Salinaro A, Condorelli DF, Bruzzone R (2002) Virtual cloning, functional expression, and gating analysis of human connexin31.9. Am J Physiol Cell Physiol 283:C960–C970
Nielsen PA, Kumar NM (2003) Differences in expression patterns between mouse connexin-30.2 (Cx30.2) and its putative human orthologue, connexin-31.9. FEBS Lett 540:151–156
Steger K, Tetens F, Bergmann M (1999) Expression of connexin 43 in human testis. Histochem Cell Biol 112:215–220
Defamie N, Berthaut I, Mograbi B, Chevallier D, Dadoune JP, Fenichel P, Segretain D, Pointis G (2003) Impaired gap junction connexin43 in Sertoli cells of patients with secretory azoospermia: a marker of undifferentiated Sertoli cells. Lab Invest 83:449–456
Matsuo Y, Nomata K, Eguchi J, Aoki D, Hayashi T, Hishikawa Y, Kanetake H, Shibata Y, Koji T (2007) Immunohistochemical analysis of connexin43 expression in infertile human testes. Acta Histochem Cytochem 40:69–75
Kotula-Balak M, Hejmej A, Sadowska J, Bilinska B (2007) Connexin 43 expression in human and mouse testes with impaired spermatogenesis. Eur J Histochem 51:261–268
Willecke K, Kirchhoff S, Plum A, Temme A, Thonnissen E, Ott T (1999) Biological functions of connexin genes revealed by human genetic defects, dominant negative approaches and targeted deletions in the mouse. Novartis Found Symp 219(76–88):88–96
Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, Rossant J (1995) Cardiac malformation in neonatal mice lacking connexin43. Science 267:1831–1834
Weider K, Bergmann M, Giese S, Guillou F, Failing K, Brehm R (2011) Altered differentiation and clustering of Sertoli cells in transgenic mice showing a Sertoli cell specific knockout of the connexin 43 gene. Differentiation 82:38–49
Francis RJ, Lo CW (2006) Primordial germ cell deficiency in the connexin 43 knockout mouse arises from apoptosis associated with abnormal p53 activation. Development 133:3451–3460
Anniballo R, Brehm R, Steger K (2011) Recognising the Sertoli-cell-only (SCO) syndrome: a case study. Andrologia 43:78–83
Gilleron J, Carette D, Durand P, Pointis G, Segretain D (2009) Connexin 43 a potential regulator of cell proliferation and apoptosis within the seminiferous epithelium. Int J Biochem Cell Biol 41:1381–1390
Lee NP, Leung KW, Wo JY, Tam PC, Yeung WS, Luk JM (2006) Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. Apoptosis 11:1215–1229
Godet M, Sabido O, Gilleron J, Durand P (2008) Meiotic progression of rat spermatocytes requires mitogen-activated protein kinases of Sertoli cells and close contacts between the germ cells and the Sertoli cells. Dev Biol 315:173–188
Giese S, Hossain H, Markmann M, Chakraborty T, Tchatalbachev S, Guillou F, Bergmann M, Failing K, Weider K, Brehm R (2012) Sertoli-cell-specific knockout of connexin 43 leads to multiple alterations in testicular gene expression in prepubertal mice. Dis Model Mech. doi:10.1242/dmm.008649
Li MW, Mruk DD, Lee WM, Cheng CY (2010) Connexin 43 is critical to maintain the homeostasis of the blood–testis barrier via its effects on tight junction reassembly. Proc Natl Acad Sci USA 107:17998–18003
Carette D, Weider K, Gilleron J, Giese S, Dompierre J, Bergmann M, Brehm R, Denizot JP, Segretain D, Pointis G (2010) Major involvement of connexin 43 in seminiferous epithelial junction dynamics and male fertility. Dev Biol 346:54–67
Bigliardi E, Vegni-Talluri M (1977) Gap junctions between Sertoli cells in the infertile human testis. Fertil Steril 28:755–758
Schleiermacher E (1980) Ultrastructural changes of the intercellular relationship in impaired human spermatogenesis. Hum Genet 54:391–404
Cavicchia JC, Sacerdote FL, Ortiz L (1996) The human blood–testis barrier in impaired spermatogenesis. Ultrastruct Pathol 20:211–218
Hejmej A, Bilińska B (2008) The effects of cryptorchidism on the regulation of steroidogenesis and gap junctional communication in equine testes. Endokrynol Pol 59:112–118
Schuppe HC, Meinhardt A (2005) Immune privilege and inflammation of the testis. Chem Immunol Allergy 88:1–14
Pérez C, Sobarzo C, Jacobo P, Jarazo Dietrich S, Theas M, Denduchis B, Lustig L (2011) Impaired expression and distribution of adherens and gap junction proteins in the seminiferous tubules of rats undergoing autoimmune orchitis. Int J Androl 34:566–577
Altay B, Turna B, Oktem G, Aktuğ H, Semerci B, Bilir A (2008) Immunohistochemical expression of connexin 43 and occludin in the rat testis after epididymal and vasal ligation. Fertil Steril 90:141–147
Lai-Cheong JE, Arita K, McGrath JA (2007) Genetic diseases of junctions. J Invest Dermatol 127:2713–2725
Paznekas WA, Karczeski B, Vermeer S, Lowry RB, Delatycki M, Laurence F, Koivisto PA, Van Maldergem L, Boyadjiev SA, Bodurtha JN, Jabs EW (2009) GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 30:724–733
Tong D, Colley D, Thoo R, Li TY, Plante I, Laird DW, Bai D, Kidder GM (2009) Oogenesis defects in a mutant mouse model of oculodentodigital dysplasia. Dis Model Mech 2:157–167
Gregory M, Kahiri CN, Barr KJ, Smith CE, Hermo L, Cyr DG, Kidder GM (2011) Male reproductive system defects and subfertility in a mutant mouse model of oculodentodigital dysplasia. Int J Androl 34:630–641
Wohlfahrt-Veje C, Main KM, Skakkebaek NE (2009) Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clin Endocrinol (Oxf) 71:459–465
Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28
Sharpe RM, McKinnell C, Kivlin C, Fisher JS (2003) Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125:769–784
Petersen PM, Skakkebaek NE, Giwercman A (1998) Gonadal function in men with testicular cancer: biological and clinical aspects. APMIS 106:24–34
Møller H, Skakkebaek NE (1999) Risk of testicular cancer in subfertile men: case-control study. BMJ 318:559–562
Jacobsen R, Bostofte E, Engholm G, Hansen J, Olsen JH, Skakkebaek NE, Moller H (2000) Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ 321:789–792
Raman JD, Nobert CF, Goldstein M (2005) Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 174:1819–1822
Olesen IA, Hoei-Hansen CE, Skakkebaek NE, Petersen JH, Rajpert-De Meyts E, Jørgensen N (2007) Testicular carcinoma in situ in subfertile Danish men. Int J Androl 30:406–411
Paul C, Povey JE, Lawrence NJ, Selfridge J, Melton DW, Saunders PT (2007) Deletion of genes implicated in protecting the integrity of male germ cells has differential effects on the incidence of DNA breaks and germ cell loss. PLoS ONE 2:989
Rajpert-De Meyts E (2006) Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12:303–323
Looijenga LH, Gillis AJ, Stoop HJ, Hersmus R, Oosterhuis JW (2007) Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann NY Acad Sci 1120:187–214
Yamasaki H, Naus CC (1996) Role of connexin genes in growth control. Carcinogenesis 17:1199–1213
Roger C, Mograbi B, Chevallier D, Michiels JF, Tanaka H, Segretain D, Pointis G, Fenichel P (2004) Disrupted traffic of connexin 43 in human testicular seminoma cells: overexpression of Cx43 induces membrane location and cell proliferation decrease. J Pathol 202:241–246
Brehm R, Rüttinger C, Fischer P, Gashaw I, Winterhager E, Kliesch S, Bohle RM, Steger K, Bergmann M (2006) Transition from preinvasive carcinoma in situ to seminoma is accompanied by a reduction of connexin 43 expression in Sertoli cells and germ cells. Neoplasia 8:499–509
Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Nishimura T, Enomoto K (2007) Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J Membr Biol 218:73–77
Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N (2004) Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol 39:763–768
Kanczuga-Koda L, Sulkowski S, Koda M, Sulkowska M (2005) Alterations in connexin26 expression during colorectal carcinogenesis. Oncology 68:217–222
Hong R, Lim SC (2008) Pathological significance of connexin 26 expression in colorectal adenocarcinoma. Oncol Rep 19:913–919
Jee H, Nam KT, Kwon HJ, Han SU, Kim DY (2011) Altered expression and localization of connexin32 in human and murine gastric carcinogenesis. Dig Dis Sci 56:1323–1332
Mauro V, Chevallier D, Gilleron J, Carette D, Defamie N, Gasc JM, Senegas-Balas F, Segretain D, Pointis G (2008) Aberrant cytoplasmic accumulation of connexin 43 in human testicular seminoma. Open Biomarkers J 1:20–27
Segretain D, Decrouy X, Dompierre J, Escalier D, Rahman N, Fiorini C, Mograbi B, Siffroi JP, Huhtaniemi I, Fenichel P, Pointis G (2003) Sequestration of connexin43 in the early endosomes: an early event of Leydig cell tumor progression. Mol Carcinog 38:179–187
Li Q, Omori Y, Nishikawa Y, Yoshioka T, Yamamoto Y, Enomoto K (2007) Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. Int J Cancer 121:536–546
Huang RP, Fan Y, Hossain MZ, Peng A, Zeng ZL, Boynton AL (1998) Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58:5089–5096
Quin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, Laird DW (2003) Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Commun Adhes 10:387–393
Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW (2006) Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 27:2528–2537
Kliesch S, Behre HM, Hertle L, Bergmann M (1998) Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol 160:1894–1898
Decrouy X, Gasc JM, Pointis G, Segretain D (2004) Functional characterization of Cx43 based gap junctions during spermatogenesis. J Cell Physiol 200:146–154
Fiorini C, Decrouy X, Defamie N, Segretain D, Pointis G (2006) Opposite regulation of connexin33 and connexin43 by LPS and IL-1alpha in spermatogenesis. Am J Physiol Cell Physiol 290:C733–C740
McLachlan E, Shao Q, Laird DW (2007) Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol 218:107–121
Francis R, Xu X, Park H, Wei CJ, Chang S, Chatterjee B, Lo C (2011) Connexin43 modulates cell polarity and directional cell migration by regulating microtubule dynamics. PLoS ONE 6:e26379
Steiner M, Weipoltshammer K, Viehberger G, Meixner EM, Lunglmayr G, Schöfer C (2011) Immunohistochemical expression analysis of Cx43, Cx26, c-KIT and PlAP in contralateral testis biopsies of patients with non-seminomatous testicular germ cell tumor. Histochem Cell Biol 135:73–81
Richiardi L, Bellocco R, Adami HO, Torrång A, Barlow L, Hakulinen T, Rahu M, Stengrevics A, Storm H, Tretli S, Kurtinaitis J, Tyczynski JE, Akre O (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 12:2157–2166
Esteves SC, Zini A, Aziz N, Alvarez JG, Sabanegh ES Jr, Agarwal A (2012) Critical appraisal of World Health Organization’s new reference values for human semen characteristics and effect on diagnosis and treatment of subfertile men. Urology 79:16–22
Walsh T, Croughan M, Schembri M, Chan J, Turek P (2009) Increased risk of testicular germ cell cancer among infertile men. MD Arch Intern Med 169:351–356
Peng X, Zeng X, Peng S, Deng D, Zhang J (2009) The association risk of male subfertility and testicular cancer: a systematic review. PLoS ONE 4:e5591
Hotaling JM, Walsh TJ (2009) Male infertility: a risk factor for testicular cancer. Nat Rev Urol 10:550–556
Favilla V, Cimino S, Madonia M, Morgia G (2010) New advances in clinical biomarkers in testis cancer. Front Biosci 1:456–477
Trigo JM, Tabernero JM, Paz-Ares L, García-Llano JL, Mora J, Lianes P, Esteban E, Salazar R, López-López JJ, Cortés-Funes H (2000) Tumor markers at the time of recurrence in patients with germ cell tumors. Cancer 1:162–168
Chieffi P (2011) New prognostic markers and potential therapeutic targets in human testicular germ cell tumors. Curr Med Chem 18:5033–5040
Huang S, Li H, Ding X, Xiong C (2009) Presence and characterization of cell-free seminal RNA in healthy individuals: implications for noninvasive disease diagnosis and gene expression studies of the male reproductive system. Clin Chem 55:1967–1976
Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A (2012) The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets 16:S103–S109
Zen K, Zhang CY (2012) Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev 32:326–348
Wang C, Yang C, Chen X, Yao B, Yang C, Zhu C, Li L, Wang J, Li X, Shao Y, Liu Y, Ji J, Zhang J, Zen K, Zhang CY, Zhang C (2011) Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem 57:1722–1731
Novotny GW, Belling K, Bramsen JB, Nielsen JE, Bork-Jensen J, Almstrup K, Sonne SB, Kjems J, Rajpert-De Meyts E, Leffers H (2012) MicroRNA expression profiling of carcinoma in situ (CIS) cells of the testis. Endocr Relat Cancer 19:365–379
Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31:659–666
Fichtlscherer S, Zeiher AM, Dimmeler S (2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31:2383–2390
Kandouz M, Batist G (2010) Gap junctions and connexins as therapeutic targets in cancer. Expert Opin Ther Targets 14:681–692
King TJ, Bertram JS (2005) Connexins as targets for cancer chemoprevention and chemotherapy. Biochim Biophys Acta 1719:146–160
Nicholas TW, Read SB, Burrows FJ, Kruse CA (2003) Suicide gene therapy with Herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects. Histol Histopathol 18:495–507
Fang X, Huang T, Zhu Y, Yan Q, Chi Y, Jiang JX, Wang P, Matsue H, Kitamura M, Yao J (2011) Connexin43 hemichannels contribute to cadmium-induced oxidative stress and cell injury. Antioxid Redox Signal 14:2427–2439
Hong X, Wang Q, Yang Y, Zheng S, Tong X, Zhang S, Tao L, Harris AL (2012) Gap junctions propagate opposite effects in normal and tumor testicular cells in response to cisplatin. Cancer Lett 317:165–171
Demetri GD, Griffin JD (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78:2791–2808
Kim J, Lee S, Jeon B, Jang W, Moon C, Kim S (2011) Protection of spermatogenesis against gamma ray-induced damage by granulocyte colony-stimulating factor in mice. Andrologia 43:87–93
Kuwabara M, Kakinuma Y, Katare RG, Ando M, Yamasaki F, Doi Y, Sato T (2007) Granulocyte colony-stimulating factor activates Wnt signal to sustain gap junction function through recruitment of beta-catenin and cadherin. FEBS Lett 581:4821–4830
Milberg P, Klocke R, Frommeyer G, Quang TH, Dieks K, Stypmann J, Osada N, Kuhlmann M, Fehr M, Milting H, Nikol S, Waltenberger J, Breithardt G, Eckardt L (2011) G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure. Basic Res Cardiol 106:995–1008
Gilleron J, Carette D, Chevallier D, Segretain D, Pointis G (2012) Molecular connexin partner remodeling orchestrates connexin traffic: from physiology to pathophysiology. Crit Rev Biochem Mol Biol. doi:10.3109/10409238.2012.683482
Yomogida K, Yagura Y, Nishimune Y (2002) Electroporated transgene-rescued spermatogenesis in infertile mutant mice with a Sertoli cell defect. Biol Reprod 67:712–717
Kojima Y, Kurokawa S, Mizuno K, Umemoto Y, Sasaki S, Hayashi Y, Kohri K (2008) Gene transfer to sperm and testis: future prospects of gene therapy for male infertility. Curr Gene Ther 8:121–134
O’Bryan MK, de Kretser D (2006) Mouse models for genes involved in impaired spermatogenesis. Int J Androl 29:76–89
Miyamoto T, Tsujimura A, Miyagawa Y, Koh E, Namiki M, Sengoku K (2012) Male infertility and its causes in human. Adv Urol 2012:384520
Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H, Huh NH (2007) REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19:363–368
Bikou O, Thomas D, Trappe K, Lugenbiel P, Kelemen K, Koch M, Soucek R, Voss F, Becker R, Katus HA, Bauer A (2011) Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model. Cardiovasc Res 92:218–225
Igarashi T, Finet JE, Takeuchi A, Fujino Y, Strom M, Greener ID, Rosenbaum DS, Donahue JK (2012) Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation. Circulation 125:216–225
Staecker H, Brough DE, Praetorius M, Baker K (2004) Drug delivery to the inner ear using gene therapy. Otolaryngol Clin North Am 37:1091–1108
Abraham MR, Henrikson CA, Tung L, Chang MG, Aon M, Xue T, Li RA, O’ Rourke B, Marban E (2005) Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ Res 97:159–167
McIver SC, Roman SD, Nixon B, McLaughlin EA (2012) miRNA and mammalian male germ cells. Hum Reprod Update 18:44–59
Anderson C, Catoe H, Werner R (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34:5863–5871
Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13:486–491
Rau F, Freyermuth F, Fugier C, Villemin JP, Fischer MC, Jost B, Dembele D, Gourdon G, Nicole A, Duboc D, Wahbi K, Day JW, Fujimura H, Takahashi MP, Auboeuf D, Dreumont N, Furling D, Charlet-Berguerand N (2011) Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat Struct Mol Biol 18:840–845
Inose H, Ochi H, Kimura A, Fujita K, Xu R, Sato S, Iwasaki M, Sunamura S, Takeuchi Y, Fukumoto S, Saito K, Nakamura T, Siomi H, Ito H, Arai Y, Shinomiya K, Takeda S (2009) A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci USA 106:20794–20799
Lian J, Zhang X, Tian H, Liang N, Wang Y, Liang C, Li X, Sun F (2009) Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol 7:13
Lian J, Tian H, Liu L, Zhang XS, Li WQ, Deng YM, Yao GD, Yin MM, Sun F (2010) Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis 1:e94
Severs NJ, Bruce AF, Dupont E, Rothery S (2008) Remodelling of gap junctions and connexin expression in diseased myocardium. Cardiovasc Res 80:9–19
Song YN, Zhang H, Zhao JY, Guo XL (2009) Connexin 43, a new therapeutic target for cardiovascular diseases. Pharmazie 64:291–295
Pointis G (2006) Connexin43: emerging role in erectile function. Int J Biochem Cell Biol 38:1642–1646
Lee SK, Teng Y, Wong HK, Ng TK, Huang L, Lei P, Choy KW, Liu Y, Zhang M, Lam DS, Yam GH, Pang CP (2011) MicroRNA-145 regulates human corneal epithelial differentiation. PLoS ONE 6:e21249
Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O’Sullivan B, Liu FF (2011) MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71:2381–2391
Parrington J, Coward K, Gadea J (2011) Sperm and testis mediated DNA transfer as a means of gene therapy. Syst Biol Reprod Med 57:35–42
Kojima Y, Mizuno K, Umemoto Y, Sasaki S, Hayashi Y, Kohri K (2011) Therapeutic potential of gene transfer to testis; myth or reality? In: Kang C (ed) Gene therapy applications. InTech. ISBN: 978-953-307-541-9. Available from: http://www.intechopen.com/books/gene-therapy-applications/therapeutic-potential-of-gene-transfer-to-testis-myth-or-reality-
Acknowledgments
The preparation of this review was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM). The authors would like to thank Laure Gilleron for critically reading the manuscript and Jeannine Colombani for secretarial assistance. JG is a doctoral and postdoctoral research fellow of the French Ministry of Research and Technology and of EMBO.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chevallier, D., Carette, D., Segretain, D. et al. Connexin 43 a check-point component of cell proliferation implicated in a wide range of human testis diseases. Cell. Mol. Life Sci. 70, 1207–1220 (2013). https://doi.org/10.1007/s00018-012-1121-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00018-012-1121-3